genedrive plc is focused on decentralising molecular diagnostics, concentrating on applications where our technology will provide sustainable growth
Diagnostics: Rapid and accurate diagnosis of infectious disease facilitating immediate therapeutic treatment.
Pharmacogenomics: Allowing medicine to be personalised around an individual patient's genotype.
Future applications: Genedrive® is being validated for use in the areas of pathogen detection & biosurveillance and aquaculture.
genedrive plc at a glance >
Share price details >
View all regulatory news >
12 December 2018
Annual Report and Accounts 2018
View all reports >
Thursday November 29, 2018
US giant AbbVie to fund trial of genedrive's hep C test
Thursday November 22, 2018
Genedrive 'well placed' to grow the business after £6mln equity raise
Friday November 16, 2018
Genedrive welcomes BGF as a cornerstone investor as it proposes to raise £6mln
View all news >
On the 8th June 2018 Genedrive Plc disposed of the business and assets of Epistem Ltd. Please follow this link to be redirected to the website of Epistem Ltd
© 2017-18 genedrive plc
Don't show this again